Clinical Trials Search | Clareo Health

Showing 1-3 of 3 trials

A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

NCT06917508

The primary aim of this study is to assess the effect of EDP-323 on the pharmacokinetics and safety of midazolam, caffeine, and rosuvastatin in healthy adult participants.

RSV InfectionDrug Drug Interaction

Enanta Pharmaceuticals, Inc24 participantsStarted Mar 2025

San Antonio, Texas, United States

COMPLETEDPHASE1

A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam

NCT05942365

This study is a single-center, open label phase I clinical study to characterize the DDIs potential of ZSP1273 With Warfarin and Midazolam in Chinese healthy participants. This study also aims to evaluate the safety and tolerability of ZSP1273 in the presence of Warfarin and Midazolam.

Drug Drug InteractionWarfarinMidazolam

Guangdong Raynovent Biotech Co., Ltd28 participantsStarted Jun 2023

Guangzhou, China

COMPLETEDPHASE1

Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate

NCT05181007

study the effect of mefanamic acid or valproate on ciprofol

Drug Drug Interaction

Haisco Pharmaceutical Group Co., Ltd.41 participantsStarted Dec 2021

Hanzhou, China

Data from ClinicalTrials.govTerms

Filters

Filters

A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam

Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate

A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam

Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate